1,663
Participants
Start Date
January 1, 2020
Primary Completion Date
July 31, 2023
Study Completion Date
December 31, 2023
Indomethacin
Intravenous formulation
Ibuprofen
Intravenous and oral formulations
Acetaminophen
Intravenous and oral formulations
Foothills Medical Centre, Calgary
Royal Alexandra Hospital, Edmonton
Royal Columbian Hospital, New Westminster
British Columbia Women's Hospital, Vancouver
Victoria General Hospital, Victoria
Health Sciences Centre, Winnipeg
St. Boniface General Hospital, Winnipeg
The Moncton Hospital, Moncton
Saint John Regional Hospital, Saint John
Kingston Health Sciences Centre, Kingston
London Health Sciences Centre, London
Children's Hospital of Eastern Ontario, Ottawa
Hospital for Sick Children, Toronto
Mount Sinai Hospital, Toronto
Sunnybrook Health Sciences Centre, Toronto
Windsor Regional Hospital, Windsor
CHU Sainte-Justine, Montreal
Centre Hospitalier Universitaire de Quebec, Québec
Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke
Regina General Hospital, Regina
Royal University Hospital, Saskatoon
IWK Health Center, Halifax
Lead Sponsor
Collaborators (2)
Provincial Health Services Authority
OTHER
Children's Hospital of Eastern Ontario
OTHER
CHU de Quebec-Universite Laval
OTHER
Foothills Medical Centre
OTHER
Victoria General Hospital
UNKNOWN
The Hospital for Sick Children
OTHER
Health Sciences Centre, Winnipeg, Manitoba
OTHER
St. Justine's Hospital
OTHER
Queen's University
OTHER
MOUNT SINAI HOSPITAL
OTHER
Royal Alexandra Hospital
OTHER
Regina General Hospital
OTHER
Royal University Hospital Foundation
OTHER
St. Boniface Hospital
OTHER
The Moncton Hospital
UNKNOWN
Horizon Health Network
OTHER
Sunnybrook Health Sciences Centre
OTHER
Windsor Regional Hospital
OTHER
Royal Columbian Hospital Foundation
OTHER
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
OTHER
London Health Sciences Centre
OTHER
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
IWK Health Centre
OTHER